Cite
APA Citation
Porter, J., Taher, A., Viprakasit, V., Kattamis, A., Coates, T. D., Garbowski, M., Dürrenberger, F., Manolova, V., Richard, F., & Cappellini, M. D. (2021). oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development. Expert review of hematology, 14(7), 633–644. http://access.bl.uk/ark:/81055/vdc_100139607530.0x00001a